Ovation Science (XCNQ:OVAT) Operating Cash Flow per Share : C$-0.01 (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Operating Cash Flow per Share?

Ovation Science's operating cash flow per share for the three months ended in Mar. 2024 was C$-0.00. Ovation Science's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 40.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Ovation Science's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:OVAT' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -7.7 Med: 26.9 Max: 40.4
Current: 40.4

During the past 7 years, Ovation Science's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.40% per year. The lowest was -7.70% per year. And the median was 26.90% per year.

XCNQ:OVAT's 3-Year OCF Growth Rate is ranked better than
84.08% of 804 companies
in the Drug Manufacturers industry
Industry Median: 7.6 vs XCNQ:OVAT: 40.40

Ovation Science Operating Cash Flow per Share Historical Data

The historical data trend for Ovation Science's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Operating Cash Flow per Share Chart

Ovation Science Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.06

-0.05

-0.03

-0.02

-0.01

Ovation Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ovation Science's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovation Science's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ovation Science's Price-to-Operating-Cash-Flow falls into.

Ovation Science Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Ovation Science's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-0.336	/	30.321
	=	-0.01

Ovation Science's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-0.085	/	34.191
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

Ovation Science Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Ovation Science's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science (XCNQ:OVAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

OVATF:USA 0VH:Germany

Address

625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6

Website

https://www.ovationscience.com

Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.

Executives

David K. Ryan

Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines